• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket

    4/29/24 5:53:03 AM ET
    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ADXN alert in real time by email

    Shares of Koninklijke Philips N.V. (NYSE:PHG) rose sharply in today's pre-market trading after reporting first-quarter results. The company also resolved the respironics personal injury and medical monitoring litigation in the US for $1.1 billion.

    Koninklijke Philips shares jumped 37.1% to $28.87 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Inno Holdings Inc. (NASDAQ:INHD) gained 33.8% to $0.8410 in pre-market trading.
    • Ryde Group Ltd. (NYSE:RYDE) gained 25.9% to $4.18 in pre-market trading after dipping 8% on Friday.
    • Akanda Corp. (NASDAQ:AKAN) climbed 21.4% to $0.1250 in pre-market trading after gaining over 12% on Friday.
    • Ocean Biomedical Inc (NASDAQ:OCEA) rose 15.7% to $1.55  in today's pre-market trading after gaining 7% on Friday.
    • Wisekey International Holding AG – ADR (NASDAQ:WKEY) shares rose 15.2% to $2.36 in pre-market trading. WISeSAT.Space, a subsidiary of WISeKey International, announced the strengthening of its strategic partnership with the Swiss Armed Forces in the space sector for 2024 and beyond.
    • SolarBank Corp (NASDAQ:SUUN) shares gained 14.1% to $6.78 in pre-market trading.
    • Fulton Financial Corporation (NASDAQ:FULT) jumped 10.8% to $17.30 in pre-market trading. Republic First Bancorp has been seized by U.S. regulators and sold to Fulton Bank, a unit of Fulton Financial Corp.
    • ImmunityBio, Inc. (NASDAQ:IBRX) shares gained 10.6% to $8.13 in pre-market trading. ImmunityBio shares jumped around 44% on Friday after the company announced overall survival results in its QUILT 3.055 study.
    • Tesla, Inc. (NASDAQ:TSLA) shares gained 7.3% to $180.54 in pre-market trading. Tesla is reportedly set to lay off 693 employees at its Nevada facilities as part of the 10% layoff announced by the company earlier this month to reduce costs amid falling EV sales and margins. The company also increased the price of its new Model 3 Performance in the U.S. by $1000, merely days after its launch.

    Losers

    • Bakkt Holdings, Inc. (NASDAQ:BKKT) fell 92.2% to $0.78 in pre-market trading. The company recently announced a 1-for-25 reverse stock split.
    • Clever Leaves Holdings Inc. (NASDAQ:CLVR) shares declined 56.8% to $1.78 in pre-market trading after the company announced voluntary delisting of common shares and SEC deregistration.
    • Addex Therapeutics Ltd  (NASDAQ:ADXN) fell 50.3% to $7.99 pre-market trading. Addex Therapeutics announced lack of statistical significance in ADX71149 Phase 2 epilepsy study.
    • iSun, Inc. (NASDAQ:ISUN) fell 18.9% to $0.1362 in pre-market trading. iSun, last week, announced rescission of reverse stock split.
    • Boqii Holding Limited (NYSE:BQ) fell 16.7% to $0.25 pre-market trading after gaining 6% on Friday.
    • NuZee, Inc. (NASDAQ:NUZE) shares fell 16% to $1.37 in pre-market trading after jumping 34% on Friday.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares declined 13.3% to $1.30 in pre-market trading after declining over 5% on Friday.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares fell 12.3% to $1.14 in pre-market trading. Biodexa shares jumped over 80% on Friday after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.
    • Nature Wood Group Limited (NASDAQ:NWGL) shares fell 11.8% to $4.45 in pre-market trading after tumbling 70% on Friday.
    • mF International Limited (NASDAQ:MFI) shares declined 10.3% to $2.09 in pre-market trading after dipping around 78% on Friday.

    Now Read This: Investor Optimism Improves Following Earnings Reports; US Stocks Notch Weekly Gains

    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $AKAN
    $BDRX
    $BKKT

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    4/24/2026$385.00Sell → Hold
    DZ Bank
    Tesla Inc.
    $TSLA
    4/20/2026$300.00 → $350.00Hold
    Jefferies
    Tesla Inc.
    $TSLA
    4/14/2026$352.00Sell → Neutral
    UBS
    Tesla Inc.
    $TSLA
    4/13/2026$500.00 → $480.00Outperform
    RBC Capital Mkts
    ImmunityBio Inc.
    $IBRX
    3/12/2026$13.00Buy
    BTIG Research
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Fulton Financial Corporation
    $FULT
    2/25/2026$24.00Neutral
    DA Davidson
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    More analyst ratings

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Sr Executive Vice President Taylor Bernadette M bought $5,884 worth of $2.50 par value Common Stock (324 units at $18.18) and gifted 425 units of $2.50 par value Common Stock, decreasing direct ownership by 0.16% to 63,472 units (SEC Form 4)

    4 - FULTON FINANCIAL CORP (0000700564) (Issuer)

    12/8/25 4:05:45 PM ET
    $FULT
    Major Banks
    Finance

    Sr Executive Vice President Fiol Andrew B bought $9,178 worth of $2.50 par value Common Stock (505 units at $18.18) and gifted 11,000 units of $2.50 par value Common Stock, decreasing direct ownership by 18% to 42,746 units (SEC Form 4)

    4 - FULTON FINANCIAL CORP (0000700564) (Issuer)

    12/4/25 4:32:41 PM ET
    $FULT
    Major Banks
    Finance

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    SEC Filings

    View All

    SEC Form 20-F filed by Ryde Group Ltd.

    20-F - Ryde Group Ltd (0001971115) (Filer)

    4/24/26 6:06:09 AM ET
    $RYDE
    Real Estate

    SEC Form 6-K filed by Addex Therapeutics Ltd

    6-K - Addex Therapeutics Ltd. (0001574232) (Filer)

    4/23/26 6:05:05 AM ET
    $ADXN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Tesla Inc.

    10-Q - Tesla, Inc. (0001318605) (Filer)

    4/22/26 9:43:00 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon returned 96,000,000 shares to the company, decreasing direct ownership by 18% to 423,743,904 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/23/26 4:05:10 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Wenger E Philip

    4 - FULTON FINANCIAL CORP (0000700564) (Issuer)

    4/14/26 3:28:26 PM ET
    $FULT
    Major Banks
    Finance

    SEC Form 4 filed by Baes Nicholas

    4 - Bakkt, Inc. (0001820302) (Issuer)

    4/8/26 6:31:27 PM ET
    $BKKT
    Finance: Consumer Services
    Finance

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tesla upgraded by DZ Bank with a new price target

    DZ Bank upgraded Tesla from Sell to Hold and set a new price target of $385.00

    4/24/26 8:02:36 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Jefferies reiterated coverage on Tesla with a new price target

    Jefferies reiterated coverage of Tesla with a rating of Hold and set a new price target of $350.00 from $300.00 previously

    4/20/26 9:26:12 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Tesla upgraded by UBS with a new price target

    UBS upgraded Tesla from Sell to Neutral and set a new price target of $352.00

    4/14/26 8:13:10 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

    April 23, 2026   Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa

    4/23/26 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Energy Constraints Emerging as Critical Factor in Sustaining AI Expansion

    AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Artificial intelligence is no longer confined to software innovation; it is increasingly becoming an energy-intensive phenomenon. As AI systems grow in size and sophistication, the computational requirements needed to train and run them are triggering a sharp rise in electricity consumption, one that is beginning to strain existing infrastructure. Data centers, once considered purely digital enablers, are now among the most power-demanding assets in the global economy. This evolution is prompting governments, utilities and private enterprises alike to reassess a critical constraint: the limiting factor in AI's

    4/23/26 8:30:00 AM ET
    $DUK
    $GEV
    $NEE
    Power Generation
    Utilities
    EDP Services
    Technology

    Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

    Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, April 23, 2026 - Addex Therapeutics (NASDAQ:ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that its spin-out company, Neurosterix, is on track to complete its Phase 1 clinical study evaluating NTX-253 in Q2 2026. NTX-253 is an investigational potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor being developed for the treatment of schizophrenia. The study is designed to generate a robust early-stage clinical data package assessing safety, tolerability, a

    4/23/26 1:00:00 AM ET
    $ADXN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Leadership Updates

    Live Leadership Updates

    View All

    Preliminary Results for the Year Ended 31 December 2025

    March 27, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company" or, together with its subsidiaries, the "Group") Preliminary Results for the Year Ended 31 December 2025 Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its audited preliminary results for the year ended 31 December 2025. For more information, please contact: Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFOTel: +44 (0)29 2048 0180www.biodexapharma.com About Biodexa The Company's lead development programs include eRapa, under development for Familial Adenoma

    3/27/26 5:00:00 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEALSQ Signs Letter of Intent to Acquire 100% of Miraex, a Swiss Quantum Interconnect Platform Company

    Geneva, Switzerland, March 24, 2026 (GLOBE NEWSWIRE) -- Strategic Acquisition via the SEALSQ Quantum Fund Strengthens its Quantum Vertical Stack SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or the "Company"), a subsidiary of WISeKey International Holding Ltd (NASDAQ:WKEY, SIX: WIHN)) and a leader in post-quantum semiconductor and cybersecurity solutions, today announced that it has signed a Letter of Intent ("LOI") to acquire 100% of the equity interest of Miraex SA ("Miraex"), a developer of photonics-based quantum interconnect solutions that bridge quantum processors and quantum networks, headquartered at the EPFL Innovation Park in Ecublens, Switzerland. The LOI provides for a 60-day exclusivi

    3/24/26 9:20:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

    March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil

    3/23/26 4:30:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cyclacel Pharmaceuticals Inc.

    SC 13G/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Subject)

    11/14/24 7:21:58 PM ET
    $CYCC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/14/24 5:12:47 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AKAN
    $BDRX
    $BKKT
    Financials

    Live finance-specific insights

    View All

    Fulton Financial Corporation Announces First Quarter 2026 Results

    LANCASTER, Pa., April 22, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ:FULT) ("Fulton" or the "Corporation") reported net income available to common shareholders of $92.2 million, or $0.51 per diluted share, for the first quarter of 2026, a decrease of $4.2 million in comparison to the fourth quarter of 2025. Operating net income available to common shareholders for the three months ended March 31, 2026 was $99.7 million(1), or $0.55 per diluted share(1), an increase of $0.3 million in comparison to the fourth quarter of 2025. "Our first quarter results reflect steady, solid profitability driven by disciplined execution of our strategy," said Fult

    4/22/26 4:45:00 PM ET
    $FULT
    Major Banks
    Finance

    Scaling Lithium Operations to Meet Surging Global Demand

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lithium mining is basically riding the same wave as electric vehicles and battery storage, and that wave is getting bigger every year. Demand has been climbing fast because lithium is a core ingredient in rechargeable batteries used in EVs, smartphones, and renewable energy systems. On the supply side, new mines take years to get up and running, so there's often a lag that keeps prices elevated. For investors, that imbalance—strong demand and slower supply growth—is a big part of what's making lithium such an attractive space right now as these Active Companies are looking for opportunities: US Critical Meta

    4/9/26 8:45:00 AM ET
    $ALB
    $LAC
    $SLI
    Major Chemicals
    Industrials
    Metal Mining
    Basic Materials

    Tesla First Quarter 2026 Production, Deliveries & Deployments

    In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026   Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin

    4/2/26 9:03:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials